Mark Heinen, See Remarks at Better Therapeutics, Inc. (BTTX), bought 5,000 shares at $1.56 ($8K) on 2022-06-10, disclosed to the SEC on 2022-06-10.
Open-market purchase of $8k BTTX by See Remarks. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| BTTX | BUY | 2022-06-28 | $4K | — | Filing → |
| BTTX | BUY | 2022-04-04 | $10K | — | Filing → |
| BTTX | BUY | 2021-12-15 | $16K | — | Filing → |